Corcept Therapeutics Incorporated
CORT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,201,860 | $3,363,629 | $2,168,844 | $2,289,929 |
| - Cash | $127,665 | $135,551 | $436,619 | $335,812 |
| + Debt | $6,936 | $151 | $1,143 | $526 |
| Enterprise Value | $5,081,131 | $3,228,229 | $1,733,368 | $1,954,643 |
| Revenue | $675,040 | $482,375 | $401,858 | $365,978 |
| % Growth | 39.9% | 20% | 9.8% | – |
| Gross Profit | $664,158 | $475,894 | $396,473 | $360,697 |
| % Margin | 98.4% | 98.7% | 98.7% | 98.6% |
| EBITDA | $138,287 | $108,324 | $113,893 | $127,953 |
| % Margin | 20.5% | 22.5% | 28.3% | 35% |
| Net Income | $139,733 | $106,140 | $101,418 | $112,512 |
| % Margin | 20.7% | 22% | 25.2% | 30.7% |
| EPS Diluted | 1.23 | 0.94 | 0.87 | 0.89 |
| % Growth | 30.9% | 8% | -2.2% | – |
| Operating Cash Flow | $198,067 | $127,039 | $120,323 | $167,892 |
| Capital Expenditures | -$2,172 | -$139 | -$413 | -$469 |
| Free Cash Flow | $195,895 | $126,900 | $119,910 | $167,423 |